Your browser doesn't support javascript.
loading
Effect of arsenic trioxide and 5-aza-2'-deoxycytidine on SHP-1, JAK3, TYK2 gene expression in K562 cells / 中国实验血液学杂志
Article de Zh | WPRIM | ID: wpr-349714
Bibliothèque responsable: WPRO
ABSTRACT
This study was purposed to explore the effects of a methylation inhibitor arsenic trioxide (As2O3, ATO) and 5-Aza-2'-deoxycytidine (5-aza-CdR) on the expression of JAK-STAT signal transduction pathway in family members JAK3, TYK2 and hematopoietic cell phosphatase SHP-1 in chronic myeloid leukemia cell line K562 and their roles in pathogenesis of leukemia. The K562 cells were divided into 3 groups:single drug-treated group, combined 2 drugs-treated group, group without drug treatment as control. The concentration of 5-aza-CdR were 0.5, 1, 2 µmol/L; the concentration of ATO was 1, 2.5, 5 µmol/L; the concentration of combined drugs was ATO 1 µmol/L + 5-aza-CdR 0.5 µmol/L, ATO 2.5 µmol/L + 5-aza-CdR 1 µmol/L, and ATO 5 µmol/L + 5-aza-CdR 2 µmol/L. The K562 cells were treated with above-mentioned concentration of drugs for 24, 48 and 72 hours, then the total RNA of cells was extracted, the JAK3, TYK2 and SHP-1 expressions were detected by real-time quantitative-PCR. The results showed that after the K562 cells were treated with ATO and 5-aza-CdR alone and their combination, the expression of SHP-1 mRNA increased, the expressions of JAK3 mRNA and TYK2 mRNA decreased along with increasing of concentration and prolonging of time, displaying the concentration and time-dependency. The SHP-1 negatively related with JAK3 and TYK2. The effect of SHP-1 on JAK3 was significantly higher than that on TYK2. It is concluded that when the K562 cells are treated with ATO and 5-aza-CdR alone and their combination, the expression of SHP-1 is up-regulated and the expressions of JAK3, TYK2 are down-regulated in concentration-and time-dependent manners, moreover the ATO and 5-aza-CdR show synergies demethylation effect. The SHP-1 gene exert effect possibly through inhibiting the JAK/STAT pathway, the JAK3 is affected more than TYK2, the JAK3 may exert more important role in TAK/STAT pathway.
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Oxydes / Pharmacologie / Composés de l'arsenic / Azacitidine / Régulation de l'expression des gènes dans la leucémie / Méthylation de l'ADN / Cellules K562 / Protein Tyrosine Phosphatase, Non-Receptor Type 6 / Janus kinase 3 / TYK2 Kinase Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2014 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Oxydes / Pharmacologie / Composés de l'arsenic / Azacitidine / Régulation de l'expression des gènes dans la leucémie / Méthylation de l'ADN / Cellules K562 / Protein Tyrosine Phosphatase, Non-Receptor Type 6 / Janus kinase 3 / TYK2 Kinase Limites du sujet: Humans langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2014 Type: Article